BMC Infectious Diseases

official impact factor 2.83

Open Access Highly Access

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

Cees van Nieuwkoop*, Jan W van't Wout, Willem JJ Assendelft, Henk W Elzevier, Eliane MS Leyten, Ted Koster, G Hanke Wattel-Louis, Nathalie M Delfos, Hans C Ablij, Ed J Kuijper, Jan Pander, Jeanet W Blom, Ida C Spelt and Jaap T van Dissel

BMC Infectious Diseases 2009, 9:131 doi:10.1186/1471-2334-9-131

Accesses  

  • Last 30 days: 104 accesses
  • Last 365 days: 1324 accesses
  • All time: 6317 accesses